Heart disease continues as America's leading killer, claiming more than 941,000 lives in 2022, according to new statistics ...

A new report published Monday found that heart disease continues to be the leading cause of death in the United States.

Cedars-Sinai experts are advocating for patients to have access to GLP-1 medications such as semaglutide as a key component to caring for and preventing cardiovascular disease.

The American Heart Association has issued the 2025 update to its annual heart disease and stroke statistics report, detailing ...

Cardiovascular diseases, which include heart disease and stroke, claimed more lives in the U.S. than all forms of cancer and ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, ...

This review examines the cardiovascular risks associated with cannabis, revealing its potential to cause severe heart health ...

Preventive cardiology prioritizes identifying and managing cardiovascular risk factors before a heart attack ever occurs.

On average, the burden of sugar-sweetened beverage intake was higher among men than women, as well as among younger adults, ...